Thank you,acgood, for sharing blog and notes.
Reading thru recent ALNY releases, it seems they go the level of disingenuousness to avoid mention of delivery details and partnership arrangements with Tekmira. The marriage has gone so sour that I feel reliable info is not possible from either company these days.
Keep up the good work.
Are you TKM and ALNY investor? I have small holdings in both, but find them so hard to follow diligently that I am losing my fortitude.
regards,
Urche
Reading thru recent ALNY releases, it seems they go the level of disingenuousness to avoid mention of delivery details and partnership arrangements with Tekmira. The marriage has gone so sour that I feel reliable info is not possible from either company these days.
Keep up the good work.
Are you TKM and ALNY investor? I have small holdings in both, but find them so hard to follow diligently that I am losing my fortitude.
regards,
Urche
Recent ALNY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 08:21:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 08:16:36 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/06/2026 09:01:20 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/06/2026 08:31:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/06/2026 08:30:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/06/2026 08:05:29 PM
- New Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management • Business Wire • 03/30/2026 05:00:00 PM
- Alnylam teams up with Viz.ai and American Heart Association to advance ATTR-CM care • IH Market News • 03/24/2026 12:36:09 PM
- Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association • Business Wire • 03/24/2026 11:30:00 AM
- Alnylam to Webcast TTR Investor Webinar • Business Wire • 03/10/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:13:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:12:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:12:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:11:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 09:04:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2026 09:03:27 PM
- Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 12:31:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 12:30:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 12:30:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 12:29:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2026 10:17:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/03/2026 09:11:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 09:10:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2026 09:09:41 PM
